Alba Antúnez Rodríguez-rekin lankidetzan egindako argitalpenak (7)

2023

  1. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

    The Lancet, Vol. 401, Núm. 10374, pp. 347-356

2022

  1. Genetic Polymorphisms in VEGFR Coding Genes (FLT1/KDR) on Ranibizumab Response in High Myopia and Choroidal Neovascularization Patients

    Pharmaceutics, Vol. 14, Núm. 8

  2. Pharmacogenetics of siponimod: A systematic review

    Biomedicine and Pharmacotherapy, Vol. 153

2021

  1. Genetic polymorphisms affecting ranibizumab response in high myopia patients

    Pharmaceutics, Vol. 13, Núm. 11

  2. Pharmacogenetic polymorphisms affecting bisoprolol response

    Biomedicine and Pharmacotherapy, Vol. 142

2020

  1. Genetic variants affecting anti-vegf drug response in polypoidal choroidal vasculopathy patients: A systematic review and meta-analysis

    Genes, Vol. 11, Núm. 11, pp. 1-13

2019

  1. Pharmacogenetics in the Treatment of Cardiovascular Diseases and its current progress regarding Implementation in the Clinical Routine

    Genes, Vol. 10, Núm. 4